Similar articles

Abstract: Understanding of the mechanism of colorectal carcinogenesis has been gaining momentum for some years on account of its high incidence and impact on the lives of individuals affected. Different genetic abnormalities have been found in colorectal cancers from different sites. For example, proximal colon cancer is usually related to the nucleotide instability pathway, as microsatellite instability (MSI). However, distal colon cancer is usually associated with specific chromosomal instability (CIN). The development of cancer at the rectum, though similar to that at the colon, displays its own unique features. These differences might be partially attributed to different embryological development and physiological circumstances. Environmental factors such as diet and alcohol intake also differ in their role in the development of tumors in the three segments, proximal colon, distal colon, and rectum. “Proximal shift” of colon cancer has been known for some time, and survival rates of colorectal cancer are higher when rectal cancers are excluded, both of which emphasize the three different segments of colorectal cancer and their different properties. Meanwhile, colonic and rectal cancers are distinctive therapeutic entities. The concept of three entities of colorectal cancer may be important in designing clinical trails or therapeutic strategies. However, the dispute about the inconsistency of data concerning the site-specific mechanism of colorectal carcinoma does exist, and more evidence about molecular events of carcinogenesis and targeted therapy needs to be collected to definitely confirm the conception.

[1] Aaltonen, L.A., Salovaara, R., Kristo, P., Canzian, F., Hemminki, A., Peltomaki, P., Chadwick, R.B., Kaariainen, H., Eskelinen, M., Jarvinen, H., et al., 1998. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N. Engl. J. Med., 338(21):1481-1487.

[2] Adam, I.J., Mohamdee, M.O., Martin, I.G., Scott, N., Finan, P.J., Johnston, D., Dixon, M.F., Quirke, P., 1994. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet, 344(8924):707-711.

[3] AHCPR (Agency for Health Care Policy and Research), 1998. Colorectal Cancer Screening. Technical Review 1. AHCPR Publication No. 98-0033. Agency for Health Care Policy and Research, Rockville, MD.

[4] Anacleto, C., Leopoldino, A.M., Rossi, B., Soares, F.A., Lopes, A., Rocha, J.C., Caballero, O., Camargo, A.A., Simpson, A.J., Pena, S.D., 2005. Colorectal cancer “methylator phenotype”: fact or artifact? Neoplasia, 7(4):331-335.

[5] Arai, T., Kino, I., 1989. Morphometrical and cell kinetic studies of normal human colorectal mucosa. Comparison between the proximal and the distal large intestine. Acta Pathol. Jpn, 39(11):725-730.

[6] Araki, K., Furuya, Y., Kobayashi, M., Matsuura, K., Ogata, T., Isozaki, H., 1996. Comparison of mucosal microvasculature between the proximal and distal human colon. J. Electron. Microsc. (Tokyo), 45(3):202-206.

[7] Bazan, V., Migliavacca, M., Zanna, I., Tubiolo, C., Corsale, S., Calo, V., Amato, A., Cammareri, P., Latteri, F., Grassi, N., et al., 2002. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study. J. Cancer Res. Clin. Oncol., 128(12):650-658.

[8] Beart, R.W., Melton, L.J.3rd, Maruta, M., Dockerty, M.B., Frydenberg, H.B., O'Fallon, W.M., 1983. Trends in right and left-sided colon cancer. Dis. Colon Rectum, 26(6): 393-398.

[9] Berrino, F., Sant, M., Verdecchia, A., Capocaccia, R., Hakulinen, T., Estève, J.E., 1995. Cancer Survival in Europe. IARC Scientific Publication No. 132. International Agency for Research on Cancer, Lyon.

[10] Bingham, S.A., Day, N.E., Luben, R., Ferrari, P., Slimani, N., Norat, T., Clavel-Chapelon, F., Kesse, E., Nieters, A., Boeing, H., et al., 2003. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet, 361(9368):1496-1501.

[11] Bingham, S.A., Norat, T., Moskal, A., Ferrari, P., Slimani, N., Clavel-Chapelon, F., Kesse, E., Nieters, A., Boeing, H., Tjonneland, A., et al., 2005. Is the association with fiber from foods in colorectal cancer confounded by folate intake? Cancer Epidemiol. Biomarkers Prev., 14(6): 1552-1556.

[12] Browning, J., Gannon, B., 1986. Mucosal microvascular organization of the rat colon. Cells Tissues Organs, 126(2): 73-77.

[13] Bufill, J.A., 1990. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann. Intern. Med., 113(10):779-788.

[14] Casillas, S., Pelley, R.J., Milsom, J.W., 1997. Adjuvant therapy for colorectal cancer: present and future perspectives. Dis. Colon Rectum, 40(8):977-992.

[15] Cho, E., Smith-Warner, S.A., Spiegelman, D., Beeson, W.L., van den Brandt, P.A., Colditz, G.A., Folsom, A.R., Fraser, G.E., Freudenheim, J.L., Giovannucci, E., et al., 2004. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J. Natl. Cancer Inst., 96(13): 1015-1022.

[16] Crerand, S., Feeley, T.M., Waldron, R.P., Corrigan, T., Hederman, W., O'Connell, F.X., Heffernan, S.J., 1991. Colorectal carcinoma over 30 years at one hospital: no evidence for a shift to the right. Int. J. Colorectal Dis., 6(4):184-187.

[17] Delattre, O., Olschwang, S., Law, D.J., Melot, T., Remvikos, Y., Salmon, R.J., Sastre, X., Validire, P., Feinberg, A.P., Thomas, G., 1989. Multiple genetic alterations in distal and proximal colorectal cancer. Lancet, 334(8659):353-356.

[18] Dimberg, J., Samuelsson, A., Hugander, A., Soderkvist, P., 1999. Differential expression of cyclooxygenase 2 in human colorectal cancer. Gut, 45(5):730-732.

[19] Elsaleh, H., Joseph, D., Grieu, F., Zeps, N., Spry, N., Iacopetta, B., 2000. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet, 355(9217):1745-1750.

[20] Enblad, P., Adami, H.O., Bergstrom, R., Glimelius, B., Krusemo, U., Pahlman, L., 1988. Improved survival of patients with cancers of the colon and rectum? J. Natl. Cancer Inst., 80(8):586-591.

[21] Erkek, B., Ozkan, N., Bayar, S., Genc, V., Ekrem, U., Kuzu, A., Aribal, D., 2007. Subsite distribution of colorectal carcinoma and implications for screening: a retrospective audit of 1771 cases. Hepatogastroenterology, 54(73): 77-80.

[22] Fearon, E.R., Vogelstein, B., 1990. A genetic model for colorectal tumorigenesis. Cell, 61(5):759-767.

[23] Fernebro, E., Halvarsson, B., Baldetorp, B., Nilbert, M., 2002. Predominance of CIN versus MSI in the development of rectal cancer at young age. BMC Cancer, 2(1):25.

[24] Frattini, M., Balestra, D., Suardi, S., Oggionni, M., Alberici, P., Radice, P., Costa, A., Daidone, M.G., Leo, E., Pilotti, S., et al., 2004. Different genetic features associated with colon and rectal carcinogenesis. Clin. Cancer Res., 10(12 Pt 1):4015-4021.

[25] Friedenreich, C., Norat, T., Steindorf, K., Boutron-Ruault, M.C., Pischon, T., Mazuir, M., Clavel-Chapelon, F., Linseisen, J., Boeing, H., Bergman, M., et al., 2006. Physical activity and risk of colon and rectal cancers: the European prospective investigation into cancer and nutrition. Cancer Epidemiol. Biomarkers Prev., 15(12): 2398-2407.

[26] Gatta, G., Faivre, J., Capocaccia, R., Ponz de Leon, M., 1998. Survival of colorectal cancer patients in Europe during the period 1978-1989. Eur. J. Cancer, 34(14):2176-2183.

[27] Gervaz, P., Bouzourene, H., Cerottini, J.P., Chaubert, P., Benhattar, J., Secic, M., Wexner, S., Givel, J.C., Belin, B., 2001. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location. Dis. Colon Rectum, 44(3):364-372.

[28] Gervaz, P., Bucher, P., Morel, P., 2004. Two colons-two cancers: paradigm shift and clinical implications. J. Surg. Oncol., 88(4):261-266.

[29] Guyot, F., Faivre, J., Manfredi, S., Meny, B., Bonithon-Kopp, C., Bouvier, A.M., 2005. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann. Oncol., 16(5):756-761.

[30] Iacopetta, B., 2002. Are there two sides to colorectal cancer? Int. J. Cancer, 101(5):403-408.

[31] Irby, K., Anderson, W.F., Henson, D.E., Devesa, S.S., 2006. Emerging and widening colorectal carcinoma disparities between Blacks and Whites in the United States (1975-2002). Cancer Epidemiol. Biomarkers Prev., 15(4): 792-797.

[32] Jass, J.R., 1991. Subsite distribution and incidence of colorectal cancer in New Zealand, 1974-1983. Dis. Colon Rectum, 34(1):56-59.

[33] Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., Thun, M.J., 2008. Cancer statistics, 2008. CA Cancer J. Clin., 58(2):71-96.

[34] Ji, B.T., Devesa, S.S., Chow, W.H., Jin, F., Gao, Y.T., 1998. Colorectal cancer incidence trends by subsite in urban Shanghai, 1972-1994. Cancer Epidemiol. Biomarkers Prev., 7(8):661-666.

[35] Jubb, A.M., Bell, S.M., Quirke, P., 2001. Methylation and colorectal cancer. J. Pathol., 195(1):111-134.

[36] Kapiteijn, E., Liefers, G.J., Los, L.C., Kranenbarg, E.K., Hermans, J., Tollenaar, R.A., Moriya, Y., van de Velde, C.J., van Krieken, J.H., 2001. Mechanisms of oncogenesis in colon versus rectal cancer. J. Pathol., 195(2): 171-178.

[37] Lanza, G., Gafa, R., Santini, A., Maestri, I., Dubini, A., Gilli, G., Cavazzini, L., 1998. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Cancer, 82(1): 49-59.

[38] Larsson, S.C., Wolk, A., 2006. Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies. Int. J. Cancer, 119(11):2657-2664.

[39] Larsson, S.C., Rutegard, J., Bergkvist, L., Wolk, A., 2006. Physical activity, obesity, and risk of colon and rectal cancer in a cohort of Swedish men. Eur. J. Cancer, 42(15): 2590-2597.

[40] Li, M., Li, J.Y., Zhao, A.L., Gu, J., 2007. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas. Oncology, 73(1-2):52-57.

[41] Miyakura, Y., Sugano, K., Konishi, F., Ichikawa, A., Maekawa, M., Shitoh, K., Igarashi, S., Kotake, K., Koyama, Y., Nagai, H., 2001. Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability. Gastroenterology, 121(6): 1300-1309.

[42] Nagtegaal, I.D., Marijnen, C.A., Kranenbarg, E.K., van de Velde, C.J., van Krieken, J.H., 2002. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am. J. Surg. Pathol., 26(3): 350-357.

[43] Nelson, R.L., Dollear, T., Freels, S., Persky, V., 1997. The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer, 80(2):193-197.

[44] Nelson, R.L., Persky, V., Turyk, M., 1998. Time trends in distal colorectal cancer subsite location related to age and how it affects choice of screening modality. J. Surg. Oncol., 69(4):235-238.

[45] Nilbert, M., Planck, M., Fernebro, E., Borg, A., Johnson, A., 1999. Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancer. Eur. J. Cancer, 35(6): 942-945.

[46] Norat, T., Lukanova, A., Ferrari, P., Riboli, E., 2002. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int. J. Cancer, 98(2):241-256.

[47] Obrand, D.I., Gordon, P.H., 1998. Continued change in the distribution of colorectal carcinoma. Br. J. Surg., 85(2): 246-248.

[48] Papadopoulos, V.N., Michalopoulos, A., Netta, S., Basdanis, G., Paramythiotis, D., Zatagias, A., Berovalis, P., Harlaftis, N., 2004. Prognostic significance of mucinous component in colorectal carcinoma. Tech. Coloproctol., 8(Suppl. 1):s123-s125.

[49] Patchett, S.E., Alstead, E.M., Saunders, B.P., Hodgson, S.V., Farthing, M.J., 1997. Regional proliferative patterns in the colon of patients at risk for hereditary nonpolyposis colorectal cancer. Dis. Colon Rectum, 40(2):168-171.

[50] Ponz de Leon, M., Marino, M., Benatti, P., Rossi, G., Menigatti, M., Pedroni, M., Di Gregorio, C., Losi, L., Borghi, F., Scarselli, A., et al., 2004. Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. Ann. Oncol., 15(6):940-946.

[51] Potter, J.D., 1999. Colorectal cancer: molecules and populations. J. Natl. Cancer Inst., 91(11):916-932.

[52] Quirke, P., Durdey, P., Dixon, M.F., Williams, N.S., 1986. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet, 328(8514):996-999.

[53] Ries, L.A.G., Young, J.L., Keel, G.E., Eisner, M.P., Lin, Y.D., Horner, M.J. (Eds.), 2007. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program.

[54] Ries, L.A.G., Melbert, D., Krapcho, M., Stinchcomb, D.G., Howlader, N., Horner, M.J., Mariotto, A., Miller, B.A., Feuer, E.J., Altekruse, S.F., Lewis, D.R., et al. (Eds.), 2008. SEER Cancer Statistics Review, 1975-2005 [WWW]. National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975_2005/results_merged/topic_survival.pdf [Accessed 06/08/2008].

[55] Roncucci, L., Fante, R., Losi, L., Di Gregorio, C., Micheli, A., Benatti, P., Madenis, N., Ganazzi, D., Cassinadri, M.T., Lauriola, P., et al., 1996. Survival for colon and rectal cancer in a population-based cancer registry. Eur. J. Cancer, 32A(2):295-302.

[56] Rothberg, P.G., Spandorfer, J.M., Erisman, M.D., Staroscik, R.N., Sears, H.F., Petersen, R.O., Astrin, S.M., 1985. Evidence that c-myc expression defines two genetically distinct forms of colorectal adenocarcinoma. Br. J. Cancer, 52(4):629-632.

[57] Saltzstein, S.L., Behling, C.A., 2007. Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: a study of 213 383 cases from the California Cancer Registry. J. Clin. Gastroenterol., 41(2):173-177.

[58] Sandhu, M.S., White, I.R., McPherson, K., 2001. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol. Biomarkers Prev., 10(5): 439-446.

[59] Shamsuddin, A.M., Phelps, P.C., Trump, B.F., 1982. Human large intestinal epithelium: light microscopy, histochemistry, and ultrastructure. Hum. Pathol., 13(9):790-803.

[60] Skinner, S.A., O'Brien, P.E., 1996. The microvascular structure of the normal colon in rats and humans. J. Surg. Res., 61(2):482-490.

[61] Stang, A., Stabenow, R., Stegmaier, C., Eisinger, B., Bischof-Hammes, E., Jockel, K.H., 2007. Unexplained inversion of the incidence ratio of colon and rectal cancer among men in East Germany. A time trend analysis including 147,790 cases. Eur. J. Epidemiol., 22(4):245-255.

[62] Steindorf, K., Jedrychowski, W., Schmidt, M., Popiela, T., Penar, A., Galas, A., Wahrendorf, J., 2005. Case-control study of lifetime occupational and recreational physical activity and risks of colon and rectal cancer. Eur. J. Cancer Prev., 14(4):363-371.

[63] Svensson, E., Grotmol, T., Hoff, G., Langmark, F., Norstein, J., Tretli, S., 2002. Trends in colorectal cancer incidence in Norway by gender and anatomic site: an age-period-cohort analysis. Eur. J. Cancer Prev., 11(5):489-495.

[64] Taal, B.G., van Tinteren, H., Zoetmulder, F.A., 2001. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stages II and III. Br. J. Cancer, 85(10):1437-1443.

[65] Terry, P., Giovannucci, E., Bergkvist, L., Holmberg, L., Wolk, A., 2001a. Body weight and colorectal cancer risk in a cohort of Swedish women: relation varies by age and cancer site. Br. J. Cancer, 85(3):346-349.

[66] Terry, P., Giovannucci, E., Michels, K.B., Bergkvist, L., Hansen, H., Holmberg, L., Wolk, A., 2001b. Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J. Natl. Cancer Inst, 93(7):525-533.

[67] Thibodeau, S.N., Bren, G., Schaid, D., 1993. Microsatellite instability in cancer of the proximal colon. Science, 260(5109):816-819.

[68] Thune, I., Lund, E., 1996. Physical activity and risk of colorectal cancer in men and women. Br. J. Cancer, 73(9): 1134-1140.

[69] Troisi, R.J., Freedman, A.N., Devesa, S.S., 1999. Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer, 85(8):1670-1676.

[70] Vobecky, J., Leduc, C., Devroede, G., 1984. Sex differences in the changing anatomic distribution of colorectal carcinoma. Cancer, 54(12):3065-3069.

[71] Voorrips, L.E., Goldbohm, R.A., van Poppel, G., Sturmans, F., Hermus, R.J., van den Brandt, P.A., 2000. Vegetable and fruit consumption and risks of colon and rectal cancer in a prospective cohort study: the Netherlands cohort study on diet and cancer. Am. J. Epidemiol., 152(11):1081-1092.

[72] Wei, E.K., Giovannucci, E., Wu, K., Rosner, B., Fuchs, C.S., Willett, W.C., Colditz, G.A., 2004. Comparison of risk factors for colon and rectal cancer. Int. J. Cancer, 108(3): 433-442.

[73] Welfare, M.R., Cooper, J., Bassendine, M.F., Daly, A.K., 1997. Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England. Carcinogenesis, 18(7):1351-1354.

[74] Wu, X.C, Chen, V.W., Steele, B., Ruiz, B., Fulton, J., Liu, L., Carozza, S.E., Greenlee, R., 2001. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997. Cancer, 92(10):2547-2554.

[75] Wu, X., Chen, V.W., Martin, J., Roffers, S., Groves, F.D., Correa, C.N., Hamilton-Byrd, E., Jemal, A., 2004. Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999. Cancer Epidemiol. Biomarkers Prev., 13(7):1215-1222.

[76] Xu, F.Y., Zhai, M.J., Dong, J.K., Wang, F.J., Jin, Y.S., Zhu, Y.M., Lai, M.D., 2006. Clinical pathological factors function differently in colonic and rectal cancer prognosis. Journal of Zhejiang University (Medical Science), 3(35): 303-310 (in Chinese).